# Aspen opens anaesthetic building as part of €100M investment in France

Aspen Pharmacare has expanded its sterile production site at Notre Dame de Bondeville in France with a new anaesthetic facility and high-speed filling lines for thrombosis products, part of a €100 million investment. The expansion will add capacity for 80 million blow-fill-seal anaesthetic units and 180 million pre-filled syringes annually, with commercial production expected in 2020.

- Type: Expansion
- Announced: 2019-06-18
- Where: Notre Dame de Bondeville, France
- Value: $112.0M (100.0M EUR)
- Jobs: 100
- Starts operating: 2020
- Status: completed
- Capacity: 80 million blow-fill-seal anaesthetic units and 180 million pre-filled syringes annually
- Products: anaesthetics, pre-filled syringes for thrombosis
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Aspen Pharmacare](https://endata.com/companies/40076.md)

## Sources

- [aspenpharma.com](https://www.aspenpharma.com/media/aspen-group-news/aspen-opens-anaesthetic-building-as-part-of-e100-million-investment-at-its-french-based-site/), 2019-06-18: "The new state-of-the-art facility for anaesthetics, together with the new high-speed pre-filled syringe filling and automatic visual inspection lines for thrombosis products, comprise a substantial part of the €100 million investment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.